Topics

‘One-size-fits-all’ treatment targets harm frail older patients with diabetes

13:02 EDT 30 Apr 2019 | Pharmaceutical Journal

HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.

Original Article: ‘One-size-fits-all’ treatment targets harm frail older patients with diabetes

NEXT ARTICLE

More From BioPortfolio on "‘One-size-fits-all’ treatment targets harm frail older patients with diabetes"

Quick Search